4.0 Review

Quantum dots and prion proteins Is this a new challenge for neurodegenerative diseases imaging?

Journal

PRION
Volume 7, Issue 5, Pages 349-358

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/pri.26524

Keywords

imaging; label; neurodegenerative disease; prion protein; quantum dots

Funding

  1. CEITEC [CZ.1.05/1.1.00/02.0068]
  2. DOC [CEITEC.01/2012]
  3. Grant Agency of the Czech Republic [GACR 102/13-20303P]
  4. IGA [TP1/2013 (EA 3b)]

Ask authors/readers for more resources

A diagnostics of infectious diseases can be done by the immunologic methods or by the amplification of nucleic acid specific to contagious agent using polymerase chain reaction. However, in transmissible spongiform encephalopathies, the infectious agent, prion protein (PrPSc), has the same sequence of nucleic acids as a naturally occurring protein. The other issue with the diagnosing based on the PrPSc detection is that the pathological form of prion protein is abundant only at late stages of the disease in a brain. Therefore, the diagnostics of prion protein caused diseases represent a sort of challenges as that hosts can incubate infectious prion proteins for many months or even years. Therefore, new in vivo assays for detection of prion proteins and for diagnosis of their relation to neurodegenerative diseases are summarized. Their applicability and future prospects in this field are discussed with particular aim at using quantum dots as fluorescent labels.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available